Abeprazan is a compound under investigation in clinical trials for its potential use as a potassium-competitive acid blocker. It is studied for applications in acute or chronic gastritis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Abeprazan?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Abeprazan hydrochloride
pharmaceutical raw material
Tegoprazan
pharmaceutical raw material
TAK 438
pharmaceutical raw material
Revaprazan hydrochloride
pharmaceutical raw material
Vonoprazan Fumarate
pharmaceutical raw material
Bepotastine besilate
pharmaceutical raw material
Pramipexole dihydrochloride hydrate
pharmaceutical raw material
Ruxolitinib hydrochloride
pharmaceutical raw material
The international HS code for Abeprazan (CAS 1902954-60-2) is 2935.90.
2935.90
2935 90 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
1-[5-(2,4-difluorophenyl)-1-(3-fluorophenyl)sulfonyl-4-methoxypyrrol-3-yl]-N-methylmethanamine
OUNXGNDVWVPCOL-UHFFFAOYSA-N
CNCC1=CN(C(=C1OC)C2=C(C=C(C=C2)F)F)S(=O)(=O)C3=CC=CC(=C3)F
Sourcing Abeprazan?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.